Nd3+ doped LuOF nanophosphors for bimodality imaging of NIR-to-NIR-II luminescence and X-Ray computed tomography
Nd3+ doped LuOF nanophosphors for bimodality imaging of NIR-to-NIR-II luminescence and X-Ray computed tomography
复制标题
DOI:
10.1016/j.jlumin.2020.117753
复制
发表时间:
2020-11
影响因子:
3.6
通讯作者:
Zhenfeng Yu;Xiao-yan Fu;Shenghui Zheng;Hongwu Zhang
中科院分区:
文献类型:
--
作者:
Zhenfeng Yu;Xiao-yan Fu;Shenghui Zheng;Hongwu Zhang
In this paper, we have designed dual-mode imaging agents LuOF: Nd3+NPs, which can provided bimodality imaging of NIR-to-NIR-II luminescence and X-Ray computed tomography. The as-prepared samples prepared by hydrothermal method possessed irregular paving stone shapes with size distribution of 10–15 nm. The structure analysis showed the samples were pure cubic phase. Under the excitation of 808 nm laser (power of 500mW/cm2), Lu0.99OF: 0.01Nd3+NPs exhibited excellent NIR-II luminescence, which main peak located at 1053 nm and NIR emission intensity reached 3.0 × 105 cps. At the same time, the X-ray attenuation value was 100HU when the content of Lu0.99OF: 0.01Nd3+NPs was only 10 mg/mL. And, the MTT arrays have confirmed the excellent biological safety of Lu0.99OF: 0.01Nd3+NPs. Furthermore, thein vivoimaging results have confirmed that Lu0.99OF: 0.01Nd3+NPs possessed not only NIR–II luminescent deep tissuein vivoimaging ability but also good computed tomography imaging ability. All these results indicated that LuOF: Nd3+NPs can be regarded as dual-mode imaging agents in future medical field.